Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Sa1889 10 Year Performance of Anti TNF Biologic Therapy in Inflammatory Bowel Disease — Lilani P. Perera (2012) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Sa1889 10 Year Performance of Anti TNF Biologic Therapy in Inflammatory Bowel Disease
Shared by
Dan Joseph Stein
Sa1889 10 Year Performance of Anti TNF Biologic Therapy in Inflammatory Bowel Disease
Article
2012
en
Authors
+6 more
LP
Lilani P. Perera
YZ
Yelena Zadvornova
DB
David G. Binion
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2020
Is Biologic Therapy in Inflammatory Bowel Disease Contributing to the Obesity Epidemic? Just Weight One Year
Aditi Mulgund
,
Dan Joseph Stein
Article
2014
Mo1181 Anti-TNF Therapy in Inflammatory Bowel Disease: Predictors of Weight Gain and Development of Obesity
Anish Patel
,
Yelena Zadvornova
,
Dan Joseph Stein
,
Amar S. Naik
,
Kari Best
,
Kathleen Idstein
,
Benson T. Massey
,
Lilani P. Perera
Article
2012
Sa1931 Anti-TNF Treatment in Inflammatory Bowel Disease Patients Diagnosed in Adolescence
Amar S. Naik
,
Nikiya Asamoah
,
Yelena Zadvornova
,
Lilani P. Perera
,
Dan Joseph Stein
,
Kia Saeian
,
Nanda Venu
Article
2006
Anti-TNF drugs in dermatology and inflammatory bowel disease - Where are we going?
Richard B. Warren
,
Christopher Em Griffiths
Article
2023
Psychometric Performance of Fatigue Scales in Inflammatory Bowel Disease
Ruth Ann Marrie
,
John D. Fisk
,
Casandra Dolovich
,
Lisa M. Lix
,
Lesley A. Graff
,
Scott Burton Patten
,
Çharles N. Bernstein
Discussion(0)
No comments yet. Be the first to comment.